PubMed Health⌕ Search

PubMed · 12895485

Thermal diffuse scattering in sub-angstrom quantitative electron microscopy-phenomenon, effects and approaches.

Abstract

This paper reviews the recent progress in the following areas. (1) In quantitative high-resolution transmission electron microscopy, the theoretically calculated images usually give better contrast than the experimentally observed ones although all of the factors have been accounted for. This discrepancy is suggested due to thermal diffusely scattered (TDS) electrons, which were not included in the image calculation. The contribution from TDS electrons is especially important if the image resolution is approaching 0.1 nm and beyond with the introduction of Cs corrected microscopes. A more rigorous multislice theory has been developed to account for this effect. (2) We proved that the off-axis holography is an ideal energy filter that even filters away the contribution made by TDS electrons in the electron wave function, but conventional high-resolution microscopy do contain the contribution made by phonon scattered electrons. (3) In electron scattering, most of the existing dynamical theories have been developed under the first order diffuse scattering approximation, thus, they are restricted to cases where the lattice distortion is small. A formal dynamical theory is presented for calculating diffuse scattering with the inclusion of multiple diffuse scattering. By inclusion of a complex potential in dynamical calculation, a rigorous proof is given to show that the high order diffuse scattering are fully recovered in the calculations using the equation derived under the distorted wave Born approximation, and more importantly, the statistical time and structure averages over the distorted crystal lattices are evaluated analytically prior numerical calculation. This conclusion establishes the basis for expanding the applications of the existing theories. (4) The 'frozen lattice' model is a semi-classical approach for calculating electron diffuse scattering in crystals arisen from thermal vibration of crystal atoms. Based on a rigorous quantum mechanical phonon excitation theory, we have proved that the frozen lattice mode is an excellent approximation and no detectable error would be possible under normal experimental conditions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhong Lin Wang. 2003. Thermal diffuse scattering in sub-angstrom quantitative electron microscopy-phenomenon, effects and approaches.. https://doi.org/10.1016/s0968-4328(03)00024-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗